empagliflozin 25 MG Oral Tablet

RxCUI
1545666
RxNorm name
empagliflozin 25 MG Oral Tablet
Display name
empagliflozin 25 MG Oral Tablet
Full name
empagliflozin 25 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JardianceEMPAGLIFLOZINCardinal Health 107, LLC5777b8a8-ada6-4950-8548-43a1de11f0752026-02-17Warnings, Adverse reactionsExact identifier
rxcui: 1545666
JardianceEMPAGLIFLOZINBoehringer Ingelheim Pharmaceuticals, Inc.faf3dd6a-9cd0-39c2-0d2e-232cb3f675652026-01-30Warnings, Adverse reactionsExact identifier
rxcui: 1545666
JardianceEMPAGLIFLOZINAphena Pharma Solutions - Tennessee, LLC8b6261f6-4bdc-462e-8af1-4064664c62f32025-10-27Warnings, Adverse reactionsExact identifier
rxcui: 1545666
JardianceEMPAGLIFLOZINA-S Medication Solutionsa77214ca-572e-485e-aae9-f7950187e5fb2023-08-08Warnings, Adverse reactionsExact identifier
rxcui: 1545666
JARDIANCEEMPAGLIFLOZINA-S Medication Solutionsf2b41c77-0abb-40ee-8578-86a748d0e19e2023-05-03Warnings, Adverse reactionsExact identifier
rxcui: 1545666

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
faf3dd6a-9cd0-39c2-0d2e-232cb3f67565empagliflozin 25 MG Oral TabletPSN31These highlights do not include all the information needed to use JARDIANCE safely and effectively. See full prescribing information for JARDIANCE. JARDIANCE ® (empagliflozin tablets), for oral use Initial U.S. Approval: 201420260130
faf3dd6a-9cd0-39c2-0d2e-232cb3f67565empagliflozin 25 MG Oral TabletSCD31These highlights do not include all the information needed to use JARDIANCE safely and effectively. See full prescribing information for JARDIANCE. JARDIANCE ® (empagliflozin tablets), for oral use Initial U.S. Approval: 201420260130
5777b8a8-ada6-4950-8548-43a1de11f075empagliflozin 25 MG Oral TabletPSN13These highlights do not include all the information needed to use JARDIANCE safely and effectively. See full prescribing information for JARDIANCE. JARDIANCE ® (empagliflozin tablets), for oral use Initial U.S. Approval: 201420260217
5777b8a8-ada6-4950-8548-43a1de11f075empagliflozin 25 MG Oral TabletSCD13These highlights do not include all the information needed to use JARDIANCE safely and effectively. See full prescribing information for JARDIANCE. JARDIANCE ® (empagliflozin tablets), for oral use Initial U.S. Approval: 201420260217
a77214ca-572e-485e-aae9-f7950187e5fbempagliflozin 25 MG Oral TabletPSN11These highlights do not include all the information needed to use JARDIANCE safely and effectively. See full prescribing information for JARDIANCE. JARDIANCE ® (empagliflozin tablets), for oral use Initial U.S. Approval: 201420230808
a77214ca-572e-485e-aae9-f7950187e5fbempagliflozin 25 MG Oral TabletSCD11These highlights do not include all the information needed to use JARDIANCE safely and effectively. See full prescribing information for JARDIANCE. JARDIANCE ® (empagliflozin tablets), for oral use Initial U.S. Approval: 201420230808
8b6261f6-4bdc-462e-8af1-4064664c62f3empagliflozin 25 MG Oral TabletPSN4These highlights do not include all the information needed to use JARDIANCE safely and effectively. See full prescribing information for JARDIANCE. JARDIANCE ® (empagliflozin) tablets, for oral use Initial U.S. Approval: 201420251027
8b6261f6-4bdc-462e-8af1-4064664c62f3empagliflozin 25 MG Oral TabletSCD4These highlights do not include all the information needed to use JARDIANCE safely and effectively. See full prescribing information for JARDIANCE. JARDIANCE ® (empagliflozin) tablets, for oral use Initial U.S. Approval: 201420251027
f2b41c77-0abb-40ee-8578-86a748d0e19eempagliflozin 25 MG Oral TabletSCD1These highlights do not include all the information needed to use JARDIANCE safely and effectively. See full prescribing information for JARDIANCE. JARDIANCE ® (empagliflozin tablets), for oral use Initial U.S. Approval: 201420230503
f2b41c77-0abb-40ee-8578-86a748d0e19eempagliflozin 25 MG Oral TabletPSN1These highlights do not include all the information needed to use JARDIANCE safely and effectively. See full prescribing information for JARDIANCE. JARDIANCE ® (empagliflozin tablets), for oral use Initial U.S. Approval: 201420230503